Microbiome data is vast and complex, but it can yield significant, unexpected and novel innovation opportunities. Yet its vastness and complexity stand in the way of making that innovation systematic.
Eagle Genomics is establishing the essential data fabric and applying network data science to drive more effective innovation.
Our platform is designed to explore wider and highly novel possibilities. Generate, evaluate and test a vastly greater number of hypotheses, reliably and repeatably — radically increasing breadth and speed to insight.
If microbiome data could speak, what would it tell us?
Eagle Genomics’ innovative approach in establishing a platform-driven ecosystem for the generation and exchange of scientific data-derived assets is of great potential value to Unilever.
Healthy animals, healthy people and a healthy planet are all interconnected. With the advanced knowledge and insights we anticipate generating from our microbiome data, the e[datascientist] will allow us to bring more relevant products to market.
As a company driven by innovation, Reckitt collaborates with partners who bring powerful new capabilities to the table so we can deliver disruptive ideas to the market.
